Pluri Inc. (TLV:PLUR)
1,518.00
-21.00 (-1.36%)
Oct 5, 2025, 3:49 PM IDT
Pluri Revenue
In the fiscal year ending June 30, 2025, Pluri had annual revenue of $1.34M USD with 309.82% growth. Pluri had revenue of $398.00K in the quarter ending June 30, 2025, with 314.58% growth.
Revenue
$1.34M
Revenue Growth
+309.82%
P/S Ratio
25.57
Revenue / Employee
$9.41K
Employees
142
Market Cap
115.11M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 1.34M | 1.01M | 309.82% |
Jun 30, 2024 | 326.00K | 39.00K | 13.59% |
Jun 30, 2023 | 287.00K | 53.00K | 22.65% |
Jun 30, 2022 | 234.00K | - | - |
Jun 30, 2021 | - | - | - |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical Industries | 56.02B |
Danel (Adir Yeoshua) | 2.84B |
Kamada | 571.15M |
Bait Bakfar | 106.25M |
BrainsWay | 155.27M |
SofWave Medical | 234.12M |
Ilex Medical | 927.57M |
Novolog (Pharm-Up 1966) | 2.04B |